Nektar Therapeutics | 流动负债



金融业
股票价格
USD
资产
USD 301.35M
现金及等价物
USD 41.03M
销售成本
USD 4.44M
流动资产
USD 281.36M
流动负债
USD 66.34M
债务
USD 0
股息收益率
0
EBIT
USD -34.35M
EBITDA
USD -31.81M
员工
137
EPS每股收益
USD -0.18
股本和储备
USD 85.09M
销售毛利
USD 13.75M
债务利息支出
USD 6.02M
利息收入
USD -0.18
贷款资金
USD 107.51M
市值
USD 9.53B
净收入
USD -37.06M
营业费用
USD 85.09M
营业利润
USD -34.35M
普通股股本
USD 19K
税前利润
USD -37.05M
销售收入
USD 24.12M
销售和管理费用
USD -0.18
股票
USD 14.46M
贸易债权人
USD 15.56M
应收帐款人
USD 0


流动负债 更改 日
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 25.49B 3.7B 2025-12
Baxter International USD 3.78B 836M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Biogen USD 3.35B 59.4M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cara Therapeutics USD 10.68M 9.48M 2025-06
Cipla INR 62.97B 8.13B 2025-09
Dr.Reddys Laboratories INR 158.31B 7.38B 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 40.14B 1.12B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Exelixis USD 405.64M 31.86M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xencor USD 86.48M 9.6M 2025-09


Nektar Therapeutics 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.